Cyclacel Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases.
Cyclacel Pharmaceuticals stock last closed at $0.30, up 6.67% from the previous day, and has decreased 77.65% in one year. It has underperformed other stocks in the Biotechnology industry by 0 percentage points. Cyclacel Pharmaceuticals stock is currently +77.78% from its 52-week low of $0.17, and -92.4% from its 52-week high of $4.00.
At the moment, there are 207.34M shares of CYCC outstanding. The market capitalization of CYCC is $63.03M. In the last 24 hours, 107.99M CYCC shares were traded.
How to Buy Cyclacel Pharmaceuticals Stock
Wondering how to invest in Cyclacel Pharmaceuticals stock? Here's how.
Decide where to buy Cyclacel Pharmaceuticals stock: You need to choose a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you choose where to buy Cyclacel Pharmaceuticals stock.
Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Deposit money your investment account: Select your payment method and add your info.
Research Cyclacel Pharmaceuticals stock: The Cyclacel Pharmaceuticals ticker symbol is CYCC. Is Cyclacel Pharmaceuticals stock a good investment? Should you buy shares of CYCC? How do CYCC's underlying business fundamentals look? Do top analysts think Cyclacel Pharmaceuticals is a good buy? Why has CYCC's stock price moved recently? (Hint: Our stock market research website can help you evaluate if CYCC is a good stock to buy).
Execute your CYCC purchase: Decide if you will purchase CYCC shares at the current market price or use a limit order to purchase CYCC stock at a specific price.
Get the latest news on your CYCC investment: Create a watchlist to key updates about your position in Cyclacel Pharmaceuticals stock.
Step 1: Decide where to buy Cyclacel Pharmaceuticals stock
You will need an online brokerage account in order to access the NASDAQ market and buy CYCC shares.
A brokerage account allows you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. Here's why:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to world financial markets: From Technology to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've picked the right brokerage, the next step is to fill out some personal info so you can invest in CYCC stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Cyclacel Pharmaceuticals stock
After you have decided on the best place to buy Cyclacel Pharmaceuticals stock, it's very important to research their stock before you invest, so you actually wrap your head around the risk as well as the opportunity.
Cyclacel Pharmaceuticals stock data
CYCC Price
$0.30
1w %
34.51%
1y %
-77.65%
5y %
-99.5%
P/E
-0.15x
P/B
-28.99x
P/S
N/A
PEG
N/A
Revenue
$43.00k
Earnings
-$11.21M
Fore. Rev. Growth
1,060.29%
Fore. Earn. Growth
N/A
Market Cap
$63.03M
Next Earnings
May 12, 2025
Next Dividend
N/A
Cyclacel Pharmaceuticals Fundamentals
WallStreetZen was created to help part-time investors do better fundamental analysis in minutes instead of hours.
Last year, CYCC revenue was $43.00k. Over the last 1 years, CYCC's revenue has grown by -89.76% per year. This was slower than the Biotechnology industry average of 45.47%.
No, Cyclacel Pharmaceuticals doesn't provide an income stream by paying out dividends.
CYCC Social Trading Data
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your CYCC purchase
There are two primary options:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are mostly fine.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to be sure you're buying or selling at a given dollar amount, place a limit order.
Click the Open Trade button and your broker will execute your order.
If you need additional info about investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Cyclacel Pharmaceuticals share?
As of Apr 29, 2025, it costs $0.30 to buy one share of Cyclacel Pharmaceuticals stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.15, you can buy 0.5 shares of CYCC.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.